Home / About Quark / Press / Press Center

Stay Connected

PR Contact
Sarah Rector
srector@quark.com
303.894.3753

Follow us on:

Twitter

Facebook

Signup for:
RSS Feed
Communications

Press Center


Leading pharmaceutical company harnesses Quark's technology to standarise its global product range

Novo Nordisk, the world's leading manufacturer of diabetes products, integrates Quark's technology to standardise materials and packaging across its product portfolio

LONDON - 3/26/2008 -

Quark Inc. announced today that Novo Nordisk, a leading healthcare company and a world leader in diabetes treatment has upgraded to the latest Quark® software to standardize materials and packaging for its global product range. The company manufactures and markets the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. With headquarters in Denmark, Novo Nordisk employs approximately 23,600 full-time employees in 79 countries, and markets its products in 179 countries.

Proven technology
For the past ten years Novo Nordisk has been a dedicated QuarkXPress® user and has continued to upgrade to each new version. Tonny Schmidt, Regulatory Affairs IT projects at Novo Nordisk explains the reason for this long-lasting partnership. "Quark continues to improve on previous versions with regular updates and enhancements. In particular we have benefited from the new measurements palette, the presence of the glyph palette, and improved tables functionality. In addition, the recent release of Quark XPert Tools has proved hugely popular internally, not only because of its great value but, when combined with the features in QuarkXPress 7, it becomes an extremely powerful design tool."

Multi-language publishing
"Our extensive global reach - we market to almost 180 countries - means that localization has always been a major challenge. As QuarkXPress 7 supports Unicode® and OpenType® fonts, it enables us to substantially streamline our multiple-language publishing, eliminate many unnecessary costs, and dramatically improve quality and productivity. We are confident that QuarkXPress 7 will provide us with efficient, trouble-free publishing - regardless of the language," continued Tonny Schmidt.

QuarkXPress Server 7
"There is a huge amount of regulation in the pharmaceutical industry, and the very nature of our business means that accuracy and consistency are paramount. There is simply no room for error. We developed an application using QuarkXPress Server 7 which allows us to upload pre-defined templates containing all the regulatory information for the labeling and instructions for our products. Our local representatives across the world can then access the artwork for the packaging material easily through a browser, which means they can simply proof read and edit spelling and hyphenation in accordance with local regulations and languages without modifying any of the key information. This guarantees complete accuracy and consistency throughout the process of proof reading and approving the printed packaging material. This not only gives us piece of mind but also eliminates errors and improves efficiency."

"Quark continues to expand its presence in a range of industry sectors outside the traditional publishing sector. We have strong presence in a variety of verticals, particularly within the pharmaceutical sector," commented Matthew Wallis, senior vice president, sales Europe and Africa. "The fact that Novo Nordisk, a global player in a highly regulated industry, chose Quark products as the core technologies to standardise key materials for their product portfolio demonstrates a high level of confidence in Quark products worldwide."

To learn more about how Novo Nordisk and many other well known brands and designers are harnassing the power of QuarkXPress 7 to create inspiring designs please visit www.ilovedesign.com.

About Novo Nordisk
Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 26,000 employees in 79 countries, and markets its products in 179 countries.

About Quark
Quark Inc. (euro.quark.com/en) provides both desktop publishing and dynamic publishing software that helps customers design and publish richly designed communications across a broad spectrum of media. Two decades ago, our flagship product - QuarkXPress - changed the course of traditional publishing. Today, not only does QuarkXPress continue to innovate in the desktop publishing market, but now Quark is revolutionizing publishing again with Quark Dynamic Publishing Solution, helping customers cost-effectively meet enterprise-scale publishing challenges by extending the benefits of advanced technologies across the publishing process. Denver-based Quark Inc. is privately held.

# # #

Quark, QuarkXPress, Job Jackets and the Quark logo are trademarks or registered trademarks of Quark, Inc. and its affiliates in the U.S. and/or other countries. All other marks are the property of their respective owners.